Related Experiment Video

Updated: Jul 8, 2025

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.5K

Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric Vaccines

Alexandra B Yonts1, Claudia Gaviria-Agudelo2, David W Kimberlin3

  • 1Department of Pediatrics, Children's National Hospital, Washington, District of Columbia.

Pediatrics
|December 14, 2023
PubMed

Insights

The Advisory Committee on Immunization Practices (ACIP) updated recommendations for pediatric vaccines, including COVID-19, meningococcal, and mpox. Discussions also covered respiratory syncytial virus (RSV) prevention strategies for infants.

Area of Science:

  • Public Health
  • Immunology
  • Pediatrics

Background:

  • The Advisory Committee on Immunization Practices (ACIP) provides critical vaccine recommendations in the US.
  • ACIP meetings are essential for updating immunization schedules based on emerging public health data.
  • Recent meetings focused on vaccines for meningococcal disease, mpox, respiratory syncytial virus (RSV), influenza, and coronavirus disease 2019 (COVID-19).

Purpose of the Study:

  • To summarize ACIP meeting proceedings relevant to the pediatric population.
  • To highlight major updates for pediatric clinicians regarding vaccine recommendations.
  • To inform healthcare providers about new immunization guidelines for children and adolescents.

Main Methods:

  • Review of proceedings from ACIP meetings held October 25-26, September 12, and September 22, 2023.
  • Focus on discussions and recommendations pertinent to pediatric immunization.
  • Synthesis of information on specific vaccines and immunization schedules.

Main Results:

  • Updated recommendations for XBB monovalent COVID-19 immunization for the 2023-2024 respiratory season.
  • Inclusion of the newly licensed pentavalent meningococcal conjugate vaccine in pediatric recommendations.
  • Consideration of mpox vaccination for high-risk young adults and discussion on RSV infant protection strategies (maternal immunization vs. nirsevimab prophylaxis).

Conclusions:

  • Key updates for pediatric clinicians include new COVID-19, meningococcal, and mpox vaccine guidance.
  • ACIP is evaluating parallel strategies for protecting infants against RSV disease.
  • These updates aim to enhance vaccine-preventable disease control in the pediatric population.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.8K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.6K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
714
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187